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Abstract
  Recently biologists want to ﬁ  nd out the signiﬁ  cant gene sets instead 
of individual gene. Many packages in different software mostly in R language 
were developed to ﬁ  nd out the gene sets which are signiﬁ  cantly regulated. 
Among them some packages are able to discover up and down regulation 
as well. Signaling pathway impact analysis (SPIA) is one of them. In this 
study an approach is mentioned which can be improved the output of SPIA. I 
proposed that using moderated t values gives more signiﬁ  cant results instead 
of using logFC (log fold change) from Limma’s output in order to calculate 
probability of perturbation in SPIA. 
  Key words:  Microarray, Gene, Signaling pathway, False discovery 
rate (FDR), Fold changes, and Moderated t value.
***
  The microarray experiment is able to compare two groups of 
samples like diseased (treatment) and normal (control) samples to ﬁ  nd out 
differentially expressed genes. In order to detect signiﬁ  cant gene sets or 
pathways several methods and packages were already developed. The Gene 
Set Enrichment Analysis (GSEA) proposed by [1]  considering the entire 
distribution of genes rather than individual genes. The GSEA approach is able 
to identify a signiﬁ  cant gene set between the treatment and control samples 
for which no single gene was found to be differentially expressed using the 
over representation analysis (ORA) approach. In addition several methods for 
gene set analysis were developed such as GSA methods [2] for alternatives to 
the ORA approach,  MaxMean statistic [3]  for summarizing gene-sets, and 
a restandardization for more precise inferences, after reducing the dimension 
of the gene expression data matrix to its ﬁ  rst principal component and then 
applied t-statistic[4], Hotelling’s T2-statistic [5] with a similar dimensional 
reduction approach. global test [6] by modeling gene expressions as random 
effects in a logistic regression model, analysis of covariance (ANCOVA) test 
[7, 8]. GSA analysis of GO terms [9].  test statistics based on the two-sample 
t-statistics [10, 11],  SAM-GS test [12] based on the SAM statistic, SAM-GS 
statistic [13] using the structure of regression model and Multivariate analysis 
of variance (MANOVA) [14] for gene set analysis. The SAM-GS test is the Revista Română de Statistică nr. 3 / 2013 39
only GSA method to concentrate on the variability present in microarray gene 
expression studies by incorporating the SAM constant into the test statistic. 
 Recently,  Tarca    et al. (2009) developed a novel signaling pathway 
impact analysis (SPIA) [15] combining probability of differential expressed 
genes and probability  of perturbation. These probabilities can be calculated 
using a bootstrap approach. This paper describes a method which is based on 
SPIA. I proposed that the probability of perturbation can be calculated using the 
moderated t values from limma [16] instead of logFC (log fold change). The 
moderated t values are considered the variation of the data within treatment and 
control samples. On the other hand logFC is not able to consider the variation of 
the data. The small variability can lead to inﬂ  ation of the t-test statistic due to very 
small denominator, and therefore genes whose average expressions corresponding 
to the two groups are extremely close can be identiﬁ  ed as signiﬁ  cant.
METHODS
  In SPIA [15], the over-representation of differential expressed genes 
in a given pathway and the abnormal perturbation of that pathway which 
measuring the expression changes across the pathway topology. These 
arguments are captured by independent probability values, PNDE (probability 
of differential expressed genes) and PPERT  (probability of perturbation). 
Tarca et al. (2009) used logFC to ﬁ  nd out the probability of perturbation. 
The proposed method is based on SPIA, just replace moderated t values [14] 
instead of logFC in order to ﬁ  nd out  the probability of perturbation and the 
probability of number of differential expressed gene remain same like SPIA. 
The logFC are not able to considered variation of the data within each treatment 
and control experiment but moderated t values are able to considered variation 
of the data.  So the PPERT can be deﬁ  ned as in the following way:
At ﬁ  rst, deﬁ  ne a gene perturbation factor as:
   PF(gi)= tgi+ ¦
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  In Eq. (1), the term tgi  moderated t values which was observed in 
limma output. The second term in Eq.(1) represents exactly the same as SPIA.
Similarly calculate the net perturbation accumulation at the level of each 
gene, ACCg, the difference between the perturbation factor and the observed 
moderated t values:
  Acc(gi)= PF(gi)- tgi  (2)
  The vector of perturbation accumulation ACC can be obtained using 
the matrix form:Romanian Statistical Review nr. 3 / 2013 40
  Acc=B.(I-B)-1.T  (3)                                                                                                             
  Except the T vector the Eq (3) is same as SPIA. The T vector can be 
obtained the following way:
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  Now following SPIA procedure the total net accumulated perturbation 
in the pathway is computed as tA= 

n
i
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1
) ( .   Therefore the probability of 
perturbation becomes:
 P PERT=P(TA tA |H0). 
  This probability can also be calculated using a bootstrap approach. 
The two types of evidence, PNDE and   PPERT are ﬁ  nally combined like SPIA 
in one global probability value, PG , which is used to rank the pathways and 
test the research hypothesis that the pathway is signiﬁ  cantly perturbed under 
the condition of study. The PG =ci - ci.ln(ci); where ci = PNDE(i). PPERT (i).
RESULTS AND DISCUSSION
  Using the bioconductor’s  SPIA packages [15]  and their colorectal 
cancer data  in this package. The current version of SPIA uses KEGG signaling 
pathway data. In order to ﬁ  nd out the signiﬁ  cant pathways in colorectal cancer 
data at ﬁ  rst I used SPIA algorithm where the object DE_Colerectal=tg1$logFC 
(http://bioconductor.org /packages/2.4/bioc/vignettes/SPIA/inst/doc/SPIA.pdf). 
Then I used my proposed approach where I used SPIA package just modifying 
the object DE_Colerectal=tg1$t. That is the names of the DE_Colerectal are 
the Entrez gene IDs corresponding to the computed moderated t-values.  In both 
cases the top 15 pathways results were presented in the following two tables. It 
was observed that overall the pPERT, pG and pGFdr were decreasing when I 
used moderated t values compare to logFC (see Table 1 and Table 2). Revista Română de Statistică nr. 3 / 2013 41
SPIA results on Colerectal cancer dataset using logFC in PPERT
Table  1
KEGG Pathway tA pNDE pPERT pG pGFdr pGFWER Status
Parkinson’s.. 5012 -12.6049 0.0000 0.03800 0.0000 0.0000 0.0000 Inhibited
Alzheimer’s.. 5010 -7.06218 0.0000 0.15100 0.0000 0.0000 0.0000 Inhibited
Focal adh..4510 62.9004 0.0000 0.0000 0.0000 0.0000 0.0000 Activated
ECM-recep..4512 19.7775 0.0024 0.0000 0.0000 0.0000 0.0000 Activated
Axon guid..4360 7.6297 0.0000 0.3990 0.0000 0.0000 0.0003 Activated
Colorectal..5210 7.2566 0.0035 0.0470 0.0016 0.0179 0.1097 Activated
MAPK sig..4010 5.4930 0.0004 0.4850 0.0019 0.0179 0.1259 Activated
Wnt sig..4310 -8.2171 0.0019 0.2130 0.0037 0.0312 0.2495 Inhibited
Regulation..4810 8.0732 0.0013 0.3610 0.0043 0.0323 0.2902 Activated
Renal cell..5211 -7.6921 0.0099 0.0880 0.0071 0.0484 0.4836 Inhibited
Dentator..5050 -0.8941 0.0023 0.6290 0.0108 0.0674 0.7421 Inhibited
Notch sig..4330 3.6119 0.0041 0.5100 0.0149 0.0852 1.0000 Activated
Circadian..4710 0.0000 0.0029 1.0000 0.0201 0.0927 1.0000 Inhibited
Tight jun..4530 1.8705 0.0043 0.6820 0.0202 0.0927 1.0000 Activated
Apoptosis..4210 -15.4708 0.0393 0.0750 0.0202 0.0927 1.0000 Inhibited
SPIA results on Colerectal cancer dataset using moderated t values in PPERT
Table 2
KEGG Pathway tA pNDE pPERT pG pGFdr pGFWER Status
Parkinson’s ..5012 -54.3523 0.0000 0.0310 0.0000 0.0000 0.0000 Inhibited
Alzheimer’s..5010 -33.2952 0.0000 0.1030 0.0000 0.0000 0.0000 Inhibited
Focal adh..4510 263.3591 0.0000 0.0000 0.0000 0.0000 0.0000 Activated
ECM-recep..4512 73.1511 0.0023 0.0000 0.0000 0.0000 0.0001 Activated
Axon guid..4360 24.8177 0.0000 0.5100 0.0000 0.0001 0.0003 Activated
Regulation..4810 61.7339 0.0014 0.0890 0.0012 0.0139 0.0832 Activated
Colorectal..5210 28.8157 0.0035 0.0440 0.0015 0.0148 0.1033 Activated
MAPK sign..4010 14.6213 0.0004 0.6660 0.0024 0.0209 0.1671 Activated
Renal cell..5211 -39.6427 0.0099 0.0430 0.0037 0.0286 0.2573 Inhibited
Wnt sig..4310 -23.0880 0.0019 0.3850 0.0061 0.0395 0.4205 Inhibited
Cytokine-cyto..4060 51.3352 0.7700 0.0010 0.0063 0.0395 0.4340 Activated
Gap junction..4540 78.4665 0.0189 0.0550 0.0082 0.0459 0.5658 Activated
Dentator..5050 -5.6547 0.0023 0.4890 0.0086 0.0459 0.5961 Inhibited
Notch sig..4330 18.5283 0.0041 0.4130 0.0123 0.0602 0.8516 Activated
Melanoma..5218 123.3965 0.1783 0.0100 0.0131 0.0602 0.9016 Activated
 A  signiﬁ  cance threshold of 5% was used on the False Discovery Rate 
(FDR) corrected p-values in order to detect pathway signiﬁ  cance. Using logFC, 
it was found that 10 pathways are signiﬁ  cant but using moderated t values 
the number of signiﬁ  cant pathways are 13. That is applying my proposed 
approach improving the outcome of SPIA . This is because of variation of the Romanian Statistical Review nr. 3 / 2013 42
data. The t values capture the variation of the data within experiment while 
logFC can’t able to capture the variation of the data. The path ways Cytokine-
cytokine receptor, Gap junction and int Dentatorubropallidoluysian atr show 
signiﬁ  cant considering the t values at the object  DE_colerectal in  SPIA.
  The SPIA two way evidence plots also indicate that using moderated 
t values in PPERT gives more number of signiﬁ  cant pathways.
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Fig. 1. SPIA two-way evidence plot for the colectal cancer dataset. Panel (a) 
indicate the evidence plot using logFC in Ppert and pnael (b) indicates the 
eveidence plot using moderated t values in PPERT. Each Pathway is represented 
by one dot. The pathways at the right of the line (2) are signiﬁ  cant after 
Bonferroni correction of the global p-values, pG. The Pathways at the right of 
the line (1) are signiﬁ  cant after a FDR correction of the global p-values, pG.
Conclusion
  Gene set or pathways analysis are more important issue in biological 
analysis from last decade. Though lot of methods already developed in this 
case, still more powerful ways need to be developed. In this paper, it was noted 
that applying moderated t values instead of logFC for calculating probability 
perturbation gives more signiﬁ   cant pathways based on FDR correction. 
Therefore, it is better to use moderated t values in SPIA where we have less 
chance to loose the information than logFC.
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